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Coppe S, Orban de Xivry JJ, Yüksel D, Ivanoiu A, Lefèvre P.
Dramatic impairment of prediction due to frontal lobe degeneration. J
Neurophysiol 108: 2957–2966, 2012. First published September 5,
2012; doi:10.1152/jn.00582.2012.—Prediction is essential for motor
function in everyday life. For instance, predictive mechanisms im-
prove the perception of a moving target by increasing eye speed
anticipatively, thus reducing motion blur on the retina. Subregions of
the frontal lobes play a key role in eye movements in general and in
smooth pursuit in particular, but their precise function is not firmly
established. Here, the role of frontal lobes in the timing of predictive
action is demonstrated by studying predictive smooth pursuit during
transient blanking of a moving target in mild frontotemporal lobar
degeneration (FTLD) and Alzheimer’s disease (AD) patients. While
control subjects and AD patients predictively reaccelerated their eyes
before the predicted time of target reappearance, FTLD patients did
not. The difference was so dramatic (classification accuracy 90%)
that it could even lead to the definition of a new biomarker. In
contrast, anticipatory eye movements triggered by the disappearance
of the fixation point were still present before target motion onset in
FTLD patients and visually guided pursuit was normal in both patient
groups compared with controls. Therefore, FTLD patients were only
impaired when the predicted timing of an external event was required
to elicit an action. These results argue in favor of a role of the frontal
lobes in predictive movement timing.
eye movements; frontotemporal dementia; Alzheimer’s disease; fron-
tal lobes; frontal eye field
PREDICTION IS A CORNERSTONE of human motor function. It is
used to improve the perception of a moving object (Orban de
Xivry and Lefèvre 2007; Barnes 2008), to avoid the slippage of
a handheld object during its transport (Flanagan and Wing
1997), or to anticipate the consequences of one’s own actions
(Blakemore et al. 2000). In the present study, we focus on
predictive mechanisms active during smooth pursuit eye move-
ments that are normally used to overcome sensorimotor delays
(Carl and Gellman 1987).
Predictive smooth pursuit eye movements are especially
highlighted when the fixation cue disappears for a few hundred
milliseconds before target motion onset (anticipatory pursuit;
Barnes 2008; Barnes and Asselman 1991, 1992; Barnes et al.
1987; Boman and Hotson 1988, 1989; Kowler 2011; Kowler
and Steinman 1979a, 1979b, 1981) or when the target tran-
siently disappears from the visual environment (Barnes 2008;
Becker and Fuchs 1985; Mitrani and Dimitrov 1978). In this
case, smooth pursuit eye movements are maintained in the
absence of visual feedback through predictive mechanisms.
During this blanking period, smooth pursuit eye velocity
decreases to a plateau value (Becker and Fuchs 1985; Orban de
Xivry et al. 2006, 2008) and is compensated for by saccades
(Orban de Xivry et al. 2006, 2009). Moreover, if the duration
of the blanking period is predictable, a predictive eye reaccel-
eration takes place before target reappearance (Bennett and
Barnes 2003, 2004; Churchland et al. 2003; Orban de Xivry et
al. 2006). This predictive reacceleration is scaled to upcoming
target velocity (Bennett and Barnes 2004; Orban de Xivry et al.
2006). It is present in experiments where target velocity at
reappearance changes from trial-to-trial but can be anticipated
from the preblanking period (Bennett et al. 2007). When the
same target motion is used in consecutive trials, it takes three
trials to build up an appropriate predictive reacceleration (Ben-
nett et al. 2010). In contrast, such a predictive reacceleration is
absent when the duration of the blanking period is unknown
(Orban de Xivry et al. 2008).
Three lines of evidence highlight the implication of the
frontal lobes in predictive smooth pursuit in humans (Sharpe
2008). First, fMRI studies found changes in activation during
predictive smooth pursuit in the frontal eye fields (FEF), the
supplementary motor area (SMA), including supplementary
eye fields (SEF), and the dorsolateral prefrontal cortex
(DLPFC) (Schmid et al. 2001; Lencer et al. 2004; Nagel et al.
2006, 2007). Second, anticipatory and visually guided smooth
pursuit eye movements are impaired in stroke patients when
frontal areas are damaged (Morrow and Sharpe 1995; Heide et
al. 1996; Lekwuwa and Barnes 1996). Third, disrupting FEF
activity by transcranial magnetic stimulation impairs predictive
pursuit whereas disrupting the SEF affects the phase around the
time of target direction reversal (Gagnon et al. 2006; Nyffeler
et al. 2008).
In monkeys, the role of the FEF and SEF subregions of the
frontal lobes in smooth pursuit is still much debated and three
hypotheses have been presented. Based on recordings of FEF
neurons during target blanking, Ferrera and colleagues sug-
gested that the FEFs contain an internal motion representation
(Barborica and Ferrera 2003, 2004; Xiao et al. 2007). Based on
smooth pursuit perturbation, Tanaka and Lisberger (2001,
2002) identified FEF neuron responses consistent with a gain
controller for visually guided pursuit. Finally, the behavior of
FEF neurons during visually guided and anticipatory smooth
pursuit might also be consistent with a role of FEF in timing
representation (de Hemptinne et al. 2008; Schoppik et al. 2008;
Li and Lisberger 2011). One goal of this study was therefore to
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investigate which function of the pursuit system will be im-
paired by the degeneration of the frontal lobes of human brain.
To do so, we compare the predictive abilities of frontotem-
poral lobar degeneration (FTLD) patients to those of age-
matched control subjects and Alzheimer’s disease (AD) pa-
tients. Previous studies have shown that a subset of FTLD
patients performed significantly worse during an antisaccade
task (Meyniel et al. 2005; Boxer et al. 2006; Garbutt et al.
2008) and exhibited a lower eye velocity during the steady-
state pursuit (Boxer et al. 2006; Garbutt et al. 2008). Some
FTLD patients could also present larger saccade latencies and
smaller visually guided saccade velocity and gain (Boxer et al.
2012; Burrell et al. 2012). FTLD is a neurodegenerative dis-
order that is associated with degeneration of the frontal and/or
anterior temporal lobes with relative sparing of more posterior
cortical regions. The FEF and the SMA are among the first
areas impaired by this neurodegenerative process (Broe et al.
2003). In contrast, the frontal lobes of AD patients are rela-
tively spared at the early stage of the disease (Nelson et al.
2009; Aries et al. 2010; Vemuri et al. 2011). Therefore, the
comparison of the predictive tracking behavior of FTLD and
AD patients will highlight the importance of the integrity of the
frontal lobes in the control of predictive smooth pursuit.
MATERIALS AND METHODS
Participants. Eye movements of 14 patients (three females) with
mild FTLD were recorded. They were between 49 and 82 yr old
(mean  62.9 yr, standard deviation  5.9 yr). FTLD patients were
diagnosed according to their presentation as behavioral and dysex-
ecutive frontotemporal dementia (FTD), semantic dementia (SD), or
progressive nonfluent aphasia (PA). All subjects met criteria of Neary
et al. (1998) for FTD (8), SD (2), or PA (4). Two FTD patients also
showed signs of motor neuron disease (MND), a well-known associ-
ation (Bak and Hodges 2001; Lomen-Hoerth et al. 2002; Lillo and
Hodges 2009). Diagnosis was supported by clinical assessment, neu-
ropsychological evaluation, magnetic resonance imaging, functional
imagery (F-18 FDG PET scanner, Tc-99m HMPAO or ECD brain
scintigraphy), and, in six patients, by cerebrospinal fluid (CSF) bio-
markers assay. One FTD patient carried a mutation in the progranulin
(GRN) gene (Chen-Plotkin et al. 2011), and another FTD patient
associated with motor neuron disease has a familial history (genetic
assessment ongoing).
Twelve AD patients (three females) participated in the same ex-
periment. They were between 58 and 85 yr old (mean  67.3 yr,
standard deviation 7.3 yr). Diagnosis of AD followed the NINCDS-
ADRDA criteria (McKhann et al. 1984). All AD patients underwent
neuropsychological assessment and structural and functional brain
imaging. In 10 AD patients, the diagnosis was corroborated by
specific biomarkers assessment: either a CSF analysis showing path-
ological levels of tau protein and/or amyloid beta42 or a 18F-
flutemetamol amyloid imaging PET scanner displaying senile plaques
in the brain (Vandenberghe et al. 2010). The positivity of CSF and/or
imaging biomarkers in the AD patients supported the diagnosis in
mild cases when the Mini-Mental State Examination (MMSE) was
above the classical threshold of 24/30 (Jack et al. 2011).
All patients were followed-up by the same neurologist that made
the diagnosis initially (A. Ivanoiu) and were reexamined 6 mo after
the eye recording to validate the diagnosis. The morphological and
functional imaging deficits were recorded by the same neurologist (A.
Ivanoiu) who was unaware of the oculomotor performances of the
patients.
Sixteen age-matched control subjects (four females) participated in
the same experiment as control (CTRL) subjects. They were between
55 and 83 yr old (mean  64.3 yr, standard deviation  4.3 yr).
Data of one FTLD patient (from FTD subgroup), one AD patient,
and one CTRL subject were excluded based on their abnormal
visually guided pursuit performance (see Data analysis). We analyzed
the data from 13 FTLD patients, 11 AD patients, and 15 CTRL
subjects. The patient demographics as well as their disease related
characteristics are summed up in Table 1. Magnetic resonance imag-
ing and functional imagery (F-18 FDG PET scan) of two typical
patients (patients FTLD5 and AD9) are shown in Fig. 1.
All procedures were approved by the Université catholique de
Louvain Ethics Committee and were in agreement with the Declara-
tion of Helsinki. All participants gave their informed consent before
participating in the experiment.
Neuropsychological testing. Patients performed a standard battery
of neuropsychological tests that measures several domains of cogni-
tion. The scores of these tests are presented in Table 2 for each patient.
In short, AD patients were in general more amnesic but less impaired
at language tests than FTLD patients. However, executive tests
yielded comparable results in FTLD and AD patients.
This Table 2 includes verbal tests (e.g., word fluencies) but also
tests of executive function: the Luria Series Test (nonverbal visuo-
spatial test) and the TMT Test (no verbal production; Table 2).
General cognitive performance was evaluated using the MMSE (Fol-
stein et al. 1975). Language was assessed using the LEXIS Graded
Naming test as well as a Semantic Fluency (animals in 2 min) and
Phonemic Fluency (P-words in 2 min) Tests (de Partz et al. 2001).
Visuo-spatial processing assessment included the Clock Drawing Test
(Rouleau et al. 1992) and the “Praxis” part of the CERAD battery
(Morris et al. 1988), which consisted in drawing four simple shapes.
Executive functions were assessed using verbal fluency tests (see
above, de Partz et al. 2001), a variant of “Luria’s Graphical or
Alternating Sequences Test,” which consisted in copying iteratively
some series of geometric forms (local battery, unpublished) and using
the “Trail Making Test.” Long-term memory assessment was com-
pleted by using the “Doors Test” of the “Doors and People Test”
(Baddeley et al. 1994) and the French adaptation of the RL/RI 16
items test (Grober and Buschke 1987; Van der Linden et al. 2004).
Stimuli. All trials started with an initial fixation during which a
yellow dot (diameter of 0.8°) was visible on one side of horizontal
meridian of the screen (between 25 and 15° of eccentricity) for 1,000
ms (Fig. 2). The stimulus disappeared for 300 ms (gap period) and
then immediately started to move toward the center at constant
velocity for 2,000 ms. After 600 ms, the target transiently disappeared
for 800 ms and then reappeared for an additional 600 ms period (test
trials). The direction (leftward or rightward) and the velocity of the
target (10, 15, or 20°/s) were kept constant within a block but changed
randomly across blocks. The duration of the block (between 20 and 25
trials) was adjusted for each subject to reduce fatigue effects. To
minimize sequence effects, the order in which the blocks were
received was randomized across subjects. The subjects were in-
structed to follow the dot even when it was blanked. Each subject or
patient performed between 8 and 12 blocks, so there were at least 30
test trials per subject per target velocity. There was a 2-min break
between two consecutive blocks to keep the subjects alert and con-
centrated.
During the first two trials as well as three other trials of each block,
the target was continuously visible (control trials) to reinforce the
continuous movement of the target. The visually guided smooth
pursuit gain was measured in these trials. Except the first two, the
control trials were randomly inserted in the block but were always
followed by at least three test trials.
Apparatus and data analysis. Subjects were seated in a dimly lit
room with their head restrained by a chin rest and a forehead rest.
They faced a 1.5-m distant tangent screen that spanned 40° of their
visual field. Stimuli were projected onto the screen with a cine8 Barco
projector (refresh rate: 100 Hz; Barco). Eye movements were recorded
at 1,000 Hz using an Eyelink 1000 (SR Research, Ottawa, Ontario,
Canada). A calibration was performed at the beginning of each block.
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Eye movements were low-pass filtered at 45 Hz. Velocity and
acceleration signals were obtained from position signals using a
central difference algorithm on a 10-ms interval. Saccade onset and
offset were detected using a 500°/s2 acceleration threshold. Those
saccades were removed from the smooth eye velocity trace (see
details in de Brouwer et al. 2002). In such a block design, three trials
are required before predictive behavior can be exhibited (Bennett et al.
2010). Therefore, the test trials were divided into early (first three test
trials, also identified as P1) and late trials (remaining test trials). The
late trials were further divided into three periods P2 (first five of
them), P3 (next five ones), and P4 (remaining trials: between 5 and 10
trials).
In test trials, we measured the residual pursuit gain as the mean
smooth pursuit velocity averaged over a 50-ms period centered at 500
ms after target disappearance, divided by target velocity. The same
measure was extracted in control trials as a proxy of the visually
guided smooth pursuit gain. All patients and subjects had a visually
guided pursuit gain 0.85, except three people (one FTLD patient,
one AD patient, and one CTRL subject) that had a pursuit gain 0.6.
These subjects were excluded from further analyses.
In test trials, the predictive smooth pursuit reacceleration was
measured as the slope of the linear fit for the smooth velocity trace
between 100 ms before target reappearance and 50 ms after this re-
appearance, i.e., before any influence of the visual feedback.
A “heat map” of saccade endpoints during blanking was computed
for each participant to analyze the saccadic behavior. The saccade
endpoint was estimated as the position of the eye when eye acceler-
ation decreased below a 500°/s2 threshold. To build the heat map,
each saccade endpoint was represented by a 3D-Gaussian curve. The
height of each Gaussian for one participant was equal to 1/x, with x
equal the total number of saccades elicited by this participant during
the blanking periods. The y-coordinate of the center of the Gaussian
curve was the horizontal position of the saccade endpoint, and the
x-coordinate of the center of the Gaussian curve was the time of
saccade offset. The heat map for one participant was obtained by
summing up all Gaussians together. The heat map for one population
was constructed as the intersubject average of the individual heat
maps. Saccades were tagged as predictive if they ended at least 200
ms after target blanking whereas earlier saccades were tagged as
visually guided because they were likely triggered before target
blanking (Orban de Xivry et al. 2009).
An analysis of the interaction between saccades and pursuit was
also performed. To do so, both the saccadic eye displacement (SAD,
sum of predictive saccade amplitudes) and smooth eye displacement
(SED, integral of smooth eye velocity during the blanking) were
obtained and normalized by the target displacement during the blank-
ing. The relationship between SAD and SED was quantified by the
slope of the linear fit between the two variables (using the function
“robustfit” in Matlab).
For the statistical analyses, data were collapsed across directions
because none of the studied parameters were influenced by the direction
of target motion. ANOVA was performed on intrasubject mean of the
different parameters with group as between-subject factor and velocity as
within-subject factors. Tukey’s post hoc test was used to evaluate one-
to-one differences. Statistical analyses were performed with Statistica
(Statsoft, Tulsa, OK).
Table 1. Demographics and imagery characteristics of the patients
Patients Age Educ Gend Type D Dur Morphological Impairment Functional Impairment
FTLD Patients
FTLD1 59 9 M SD 50 Temporal pole L, frontal L Temporal, fronto-lateral and parietal L
FTLD2 63 18 M FTD$ 19 Temporo-polar R Frontal medial, orbital and temporal
poles R
FTLD3 59 20 M PA 25 Normal Fronto-lateral, inferior and SMA L
FTLD4 60 18 M FTD 30 Fronto-insular R Bifrontal; temporo-polar R
FTLD5 58 12 M FTD 24 Bifrontal Bifrontal; temporo-parietal R
FTLD6 69 18 M SD 24 Bitemporo-polar L Temporal L
FTLD7 73 12 F PA 40 Diffuse atrophy Bifrontal; premotor, temporal and
parietal R
FTLD8 66 18 F FTD 42 Bifrontal (basal) and subcortical Bifrontal
FTLD9 82 20 M PA 60 Diffuse atrophy Frontal lateral premotor L
FTLD10 55 18 M FTD$ 12 Diffuse atrophy Frontal L
FTLD11 49 10 F PA 16 Temporal L Temporal L
FTLD12 63 12 M FTD 50 Vertex and para hippo L Frontal L
FTLD13 62 18 M FTD 48 Frontal dorso-lateral and inferior L Bitemporal
Mean 62.9 15.6 10/3 33.8
AD Patients
AD1 58 9 M / 48 Quite normal Superior parietal L
AD2 60 20 F / 30 Slight diffuse and medial temporal Parietal L
AD3 63 15 M / 20 Slight diffuse and medial temporal Parietal and lateral temporal R
AD4 68 15 M / 18 Slight diffuse and medial temporal L Bilateral superior parietal
AD5 59 18 M / 62 Slight bi-temporal atrophy Parietal and posterior temporal R
AD6 79 14 M / 66 Diffuse and medial temporal atrophy Posterior temporal R
AD7 63 20 F / 50 Medial temporal atrophy Parietal and posterior temporal R
AD8 74 15 M / 39 Slight bi-temporal atrophy Posterior temporal R
AD9 85 15 M / 72 Medial temporal atrophy Medial temporal and anterior and
posterior cingulate cortex
AD10 71 16 F / 60 Slight diffuse and medial temporal Posterior temporal L
AD11 61 18 M / 42 Slight diffuse and medial temporal Parietal and posterior temporal L
Mean 67.3 15.9 8/3 46
Educ, education (in yr); Gend, gender; Type, syndrome for frontotemporal lobar degeneration (FTLD) patients; FTD, frontotemporal behavioral subtype; SD,
semantic dementia subtype; PA, progressive aphasia subtype; $, FTD patients with motor neuron disease; D Dur, disease duration (in months) from the first
symptoms observed by the patient (or his/her family) until the moment of the eye assessment; AD, Alzheimer’s disease. Morphological and functional imaging
deficits are based on the visual appreciation of the neurologist who was unaware of the oculomotor performances of the patients. For impairments: L, left; R,
right.
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RESULTS
Visually guided and predictive smooth pursuit. In control
trials (target continuously visible), the performance of the smooth
pursuit response was comparable across groups (Fig. 3A, dashed
traces). This indicates that visually guided pursuit was normal in
FTLD and AD patients in early course of the disease compared
with age-matched control subjects [ANOVA: main effect of
group on visually guided smooth pursuit gain: F(2,36)  0.81,
P  0.57]. In test trials, when the target was blanked, subjects
continued to track the target with the same eye velocity for
another 100 ms before it decreased exponentially towards a pla-
teau level. During the first three test trials of each block (early test
trials), eye velocity continued to decay slowly until 100 ms after
target reappearance, i.e., when visual feedback of target motion
became available and elicited a visually guided reacceleration
(Fig. 3A, solid traces). In these trials, subjects from all groups
exhibited a similar behavior.
In the late test trials (all test trials except the first three, i.e.,
periods P2 to P4), the decay in eye velocity was similar to the
one observed during the early trials for all groups. However,
200 ms before target reappearance, subjects from the CTRL
and AD groups increased their eye velocity and exhibited a
positive predictive reacceleration (Fig. 3B, blue and green
traces, respectively). In contrast, FTLD patients failed to reac-
celerate predictively (Fig. 3B, red trace). Rather, eye reaccel-
eration was prompted by the visual feedback of the target after
its reappearance, similarly to what happened in the early trials
(100 ms after target reappearance).
Oculomotor performance was quantified by the measure of
pursuit gain 500 ms into the blanking period to assess the decay
in eye velocity and by the eye acceleration at the end of the
blanking period to assess the predictive reacceleration. The
between-group differences were analyzed over the course of
the block (periods P1 to P4, see MATERIALS AND METHODS) and
for the late trials only (P2 to P4 merged together).
As illustrated in Fig. 4, pursuit gain 500 ms into the blanking
period was very similar across groups [Fig. 4A; ANOVA, main
effect of group: F(2,144) 1.27, P 0.38] and did not evolve
over the course of the blocks [ANOVA, main effect of period:
F(3,144)  0.29, P  0.83]. Moreover, there was no between-
group difference in residual velocity when it was measured
from 400 to 600 ms. Comparison of the individual data from all
subjects (Fig. 4B) revealed that the residual pursuit gain was
quite variable across subjects but had a similar range for all
three groups {Fig. 4B: CTRL: [0.31, 0.87]; FTLD: [0.33, 0.87];
AD: [0.26, 0.86]; ANOVA, main effect of group: F(2,36) 
0.17, P  0.85}.
In contrast, the evolution of the predictive reacceleration from
P1 to P4 differed across the populations [Fig. 4C, ANOVA,
groups by periods interaction: F(6,144) 4.6, P 0.00027]. This
interaction was observed for the three different target velocities
separately [ANOVA, groups by periods interaction: 10°/s:
F(6,144) 3.6, P 0.0021; 15°/s: F(6,144) 6.2, P 0.00001;
20°/s: F(6,144) 4.5, P 0.0003]. Initially, as noted in Fig. 3A,
the acceleration around the time of target reappearance was neg-
ative (no evidence of predictive reacceleration for P1) and similar
across groups [ANOVA, F(2,36)  0.97, P  0.39]. However,
this acceleration became positive from P1 to P2 for the CTRL and
AD groups (P1 vs. P2 Tukey’s post hoc: CTRL: P  0.000018;
AD: P  0.000023) but not for the FTLD group (P  0.99). For
the controls and AD patients, this predictive reacceleration did not
improve further and was maintained until the end of the block. For
the FTLD group, the acceleration around the time of target reap-
pearance never became positive, even at the end of the blocks.
Therefore, during late trials, predictive reacceleration was signif-
icantly higher in CTRL and AD groups than in the FTLD group
[ANOVA, t(26)23.7, P  0.00001; and t(22)10.8, P 
0.003]. This effect is significant for each target velocity separately
(10°/s: P 0.00001 and P 0.005; 15°/s: P 0.00001 and P
0.00001; and 20°/s: P  0.00001 and P  0.00003).
Interindividual variability of reacceleration during all late
trials was very low within groups (Fig. 4D). All subjects from
the control group (n  15) exhibited a positive reacceleration
around the time of target reappearance. Only one from the AD
group (n  11) did not (patient AD2). Moreover, the excluded
control subject and AD patient also showed a predictive reac-
celeration. In contrast, only two of the FTLD patients (n  13)
showed signs of predictive reacceleration (patients FTLD6 and
FTLD2). The excluded FTLD patient did not reaccelerate
predictively. There was no difference in predictive reaccelera-
tion between the three FTLD subgroups.
Given the very small overlap in predictive reacceleration
across groups, the absence of predictive reacceleration could
be considered as a potential biomarker for FTLD. This bio-
marker has a sensitivity of 85% (11/13). Its specificity
between CTRL and FTLD is 100% (15/15) and between AD
and FTLD is 91% (10/11). Sensitivity and specificity mea-
FTLD
AD
A
B
Fig. 1. Typical brain imaging of FTLD and AD patients. Magnetic resonance
imaging and functional imagery (F-18 FDG PET scan) of one typical fronto-
temporal lobar degeneration (FTLD) patient, with frontal lobes impairment (A,
patient FTLD5), and of one typical Alzheimer’s disease (AD) patient, with
medial temporal lobe impairment (B, patient AD9).
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sures are improved if the subjects that were excluded because
of low visually guided pursuit gain are included in the analysis.
Sensitivity becomes 86% (12/14). Specificity between CTRL
and FTLD remains at 100%. Specificity between AD and
FTLD increases to 92% (11/12). In contrast, the neuropsycho-
logical data did not separate FTLD patients from AD patients
as accurately as the predictive reacceleration (Table 2). As
expected, AD patients were in general more amnesic but less
impaired at language tests than FTLD patients. However, the
variability across patients was quite high. In addition, the
executive tests were comparable across the two groups of
patients.
Predictive smooth pursuit before target motion onset. The
absence of predictive reacceleration in the FTLD group could
be due either to the inability to elicit any predictive action or to
the inability to know when the target will reappear. Indeed, in
absence of timing information, no predictive reacceleration is
observed (Orban de Xivry et al. 2008). In the present experi-
ment, predictive mechanisms could also be observed during the
300-ms gap period that took place immediately before target
motion onset. In this case, the extinction of the fixation cue
elicited anticipatory smooth eye movements in the absence of
visual motion signals. On average, smooth eye velocity reached
21% of target velocity by the time of target motion onset. This
percentage did not differ across the groups [ANOVA, F(2,36) 
0.15, P  0.86]. Therefore, the ability to elicit predictive smooth
pursuit before target motion was comparable across groups.
Table 2. Neuropsychological results for all patients
Patients MMSE
Da
MM
Da
NP Den, %
Se
Fl
Ph
Fl
Clock
(/8)
CER
(/11)
Luria
(/32)
TMT Ti
(B-A)
TMT Er
(B-A)
Doors
(/24)
RL/RI16 Sum of
3 Trials (/48)
RL/RI16 Delayed
Recall (/16)
FTLD1 27 5 5 0.47 11 83 6 10 30 45 0 21 15 5
FTLD2 28 0 0 0.68 19 7 7 11 26 50 0 17 17 6
FTLD3 24 2 2 0.85 7 6 7 10 27 87 0 15 25 12
FTLD4 28 1 1 0.93 31 12 3 9 20.5 58 0 18 23 10
FTLD5 29 0 0 0.82 29 15 7 9 23 108 3 16 30 14
FTLD6 21 3 3 0.13 10 3 7 11 31 41 0 17 9 2
FTLD7 27 0 11 0.86 15 5 6 10 / / / / / /
FTLD8 22 0 7 0.84 19 20 5 9 20 344 6 16 26 10
FTLD9 27 2 2 0.66 8 4 3 9 19 90 1 8 16 6
FTLD10 28 5 5 0.79 21 5 7 10 27 204 4 12 24 12
FTLD11 24 0 0 0.34 8 4 1 7 6 285 6 13 20 7
FTLD12 24 4 4 0.84 28 14 7 8 25 59 0 5 8 2
FTLD13 30 3 3 0.9 27 14 8 10 29 51 0 21 22 5
AD1 27 4 4 0.91 20 21 6 10 31 56 1 12 10 6
AD2 24 2 2 0.92 25 19 8 11 30.5 37 0 12 5 3
AD3 26 3 15 0.89 21 22 8 10 31 62 0 12 6 2
AD4 22 6 6 0.92 25 13 5 10 28.5 88 1 13 3 1
AD5 28 2 30 0.85 18 20 7 6 19.5 95 1 11 6 3
AD6 28 0 20 0.81 14 7 8 10 22.5 261 5 12 9 2
AD7 23 5 5 0.88 28 17 5 9 15 402 7 9 3 0
AD8 27 9 9 0.78 22 9 7 9 21.5 42 1 7 13 5
AD9 27 1 12 0.84 29 12 8 11 16.5 69 2 16 10 5
AD10 25 0 16 0.94 36 17 7 9 27.5 85 0 14 13 2
AD11 24 4 4 0.80 24 21 5 8 20.5 209 0 17 8 2
MEAN FTLD 25.9 1.9 3.3 0.70 17.7 9.5 5.7 9.4 23.7 118 1.7 14.9 18.8 7.6
MEAN AD 25.5 3.3 11 0.87 24.4 16.2 6.7 9.4 25.7 125 1.6 12.3 7.8 2.7
MMSE, Mini Mental State Examination (/30); Da MMSE, number of months between MMSE and eye recording; Da NP, number of months between
neuropsychological examination and eye recording; Den, Denomination task (2 variants of the task: /64 for individuals older than 60 years and /80 for younger
individuals. Performance is reported as percentage of correct response); Se Fl, Semantic Fluency (number of animals in 2 min); Ph Fl, Phonemic Fluency (number
of P-words in 2 min); Clock, Clock Test (/8); CER, Praxis part of CERAD battery (drawing 4 simple shapes; /11); LURIA, variant of “Luria’s graphical or
alternating sequences test” (/32); TMT Ti, Trail-Making Test Time (Time of Part B – Time of Part A); TMT Er, Trail-Making Test Errors (number of errors
in Part B – number of errors in Part A); Doors, sum of the 2 sets of 12 doors (/24); RL/RI16, French adaptation of Grober and Buschke (1987) task with 3 learning
trials of 16 items including a support at encoding phase by semantic category cueing. Among the different scores available we considered free recall 1–3 (/48)
and free recall after 20 min (last column, /16). Underlined results are considered pathological (results inferior to 2 standard deviations away from healthy controls
mean, weighted by age and education of each patient). Numbers in parenthesis represent maximum possible score for each test when relevant. Patient FTLD7
did not conclude all tests. The 2 last lines show mean results for FTLD group and for AD group. Bold indicates significant difference between the 2 groups
(ANOVA with Tukey post hoc, P  0.05).
Fig. 2. Test trials used in the experiments. A yellow target was projected on a
black screen. After one second, a 300-ms gap period preceded target motion
onset. Then, target moved at a constant velocity for 2 s. Target was visible the
first 600 ms and then was blanked for 800 ms (test trials). Target was visible
again the last 600 ms of the trial. Target velocity (10, 15, or 20°/s) and
direction (from left to right, as illustrated, or from right to left) were randomly
chosen in the beginning of a block, and were kept constant into the block.
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Predictive saccades. The absence of predictive reaccelera-
tion for FTLD patients could be explained by a difference in
strategy. Indeed, rather than tracking the target during the
blanking period, FTLD patients could focus on the position of
the target at its reappearance. Following this assumption,
saccade endpoints should differ across the groups by being
closer to the position of the target at its reappearance for the
FTLD group. However, a difference in saccade endpoint was
not observed (Fig. 5). In Fig. 5, eye positions at the end of the
saccades are represented in function of time with the red color
corresponding to places where saccade endpoints were often
observed and the blue colored areas representing places where
very few saccades landed. Most predictive saccades landed
ahead of the target (red colored areas are located above the
white line). Importantly, this feature was present for all three
groups and the distribution of predictive saccades did not differ
across the groups (Fig. 5). For instance, position error was
similar across the three groups at the end of the first and second
predictive saccades [ANOVA, first saccade: F(2,36)  0.82,
P  0.49; second saccade: F(2,36)  1.03, P  0.59].
Therefore, the strategy appeared comparable across groups.
Interaction between saccades and pursuit. During blanking
of the target, the amplitude of the saccades is adjusted to
the level of the eye velocity decay on a trial-to-trial basis (e.g.,
Fig. 6A). A difference in modulation of the saccadic amplitude by
the smooth pursuit performance across populations would high-
light a deficit in internal representation of target motion as this
modulation depends on where the target is during the blanking
period. This modulation is revealed by the strong correlation
between the SED (how much smooth pursuit moved the eyes) and
the SAD (how much the saccades moved the eyes) during the
blanking period (see MATERIALS AND METHODS). The SED is pre-
dominantly determined by the eye velocity decay and not by the
predictive reacceleration, which happened too late to largely in-
fluence the smooth eye displacement. The correlation between
SED and SAD is illustrated for a typical FTLD patient in Fig. 6A.
This plot shows that the intertrial variability of the smooth eye
displacement during the blanking was quite high (variability along
the x-axis) but that the saccades largely compensated for this
variability. Indeed, in trials during which the smooth eye displace-
ment was small, saccadic displacement was large (Fig. 6A, point
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Fig. 3. Average smooth pursuit velocity of FTLD patients (red traces), of AD
patients (green traces), and of control (CTRL) subjects (blue traces). A: eye
velocity profiles for the control (dashed traces) and early test trials (solid
traces; first three trials of each block). B: eye velocity profile for the late test
trials, i.e., all test trials except the first three. Grey area represents the blanking
period for the test trials. Darker areas represent the periods where the residual
pursuit gain and the predictive reacceleration were measured for the test trials.
Target was moving rightward at 20°/s.
A                                                    B
C                                                    D
Fig. 4. Predictive behavior analysis. A: evolution of the
residual pursuit gain during blanking through trials for
FTLD patients (red traces), CTRL subjects (blue traces),
and AD patients (green traces) within the blocks (P1 to
P4). B: residual pursuit gain during blanking for the “late
trials” (P2 to P4). All patients and subjects are repre-
sented separately with a dot. C: evolution of the predic-
tive reacceleration within the blocks for the three groups.
D: predictive reacceleration for the three groups and
individual subjects. In B and D, each point represents the
average for one subject across the three target velocities.
Spreads represent the 95% confidence intervals.
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1). In contrast, when the smooth eye displacement was large, the
saccadic displacement was reduced (Fig. 6A, point 2). In both
cases, the synergy between saccades and pursuit allowed the eyes
to be close to the target at its reappearance (target position corre-
sponds to the dashed trace). To quantify the synergy between
saccades and pursuit, the slope of the linear fit performed on the
SED-SAD relationship (solid trace) was used. Perfect synergy
would correspond to a slope of1. In the experiment, the synergy
between saccades and pursuit did not differ across groups [Fig.
6B; ANOVA, F(2,36)  0.56, P  0.57] and did not differ from
the ideal slope for each group separately (t-tests, CTRL: P 0.84;
FTLD: P  0.23; AD: P  0.4).
DISCUSSION
In the present study, the smooth pursuit response of mild
FTLD patients during a visually guided and a predictive
tracking task was compared with the performance of control
subjects and mild AD patients. All groups had normal visually
guided pursuit responses. During the blanking, eye velocity
dropped in all groups to a “plateau level.” After some practice,
eye velocity increased before target reappearance in control
subjects and AD patients but failed to recover predictively in
FTLD patients. All other measures of oculomotor performance
during the blanking period were similar across the groups. For
instance, the ability to elicit anticipatory action before target
motion onset and to maintain an accurate internal representa-
tion of target motion during the blanking was comparable
across groups. These results suggest that subtle and specific
oculomotor deficiencies are present in the early course of
FTLD. This impairment in predictive reacceleration is a po-
tential biomarker of early stage of FTLD, which can help the
clinician in the early differential diagnosis between neurode-
generative disorders. This also highlights the role of the frontal
lobes in prediction.
What FTLD tells us about the smooth pursuit system. Pri-
mate studies have suggested that the FEF could play a critical
role in the maintenance of the internal representation of target
motion during a blanking period (Barborica and Ferrera 2003,
2004; Xiao et al. 2007), in the gain control mechanisms of
visually guided pursuit (Tanaka and Lisberger 2001, 2002),
and in the timing representation during smooth pursuit (Schop-
pik et al. 2008; Li and Lisberger 2011).
The present results suggest that mild degeneration of the
frontal lobes affects the timing function first. Indeed, while
FTLD patients had an impaired predictive reacceleration, their
dynamic internal representation of target motion was not im-
paired, as assessed either by the endpoint of predictive sac-
cades or by the synergy between saccades and pursuit during
the blanking periods. Neither was there an impairment of the
gain control mechanism as assessed by the gain of visually
guided pursuit.
However, the ability of eliciting anticipatory eye movements
was still present in FTLD patients as they were able to elicit
them before target motion onset (i.e., during the initial gap
period). In this case, the disappearance of the fixation point
could act as a “go signal” for all subjects, which could help
them to anticipate target motion onset. In contrast, the long
blanking period with the absence of go cue prevented them to
reaccelerate predictively.
Interestingly enough, this impairment is not present in mild
AD patients, which reflects the particular involvement of the
frontal lobes in predictive reacceleration. Indeed, frontal lobes
are deteriorated early in the degeneration process in FTLD
patients but are relatively spared during the early stages of the
AD (Nelson et al. 2009; Aries et al. 2010; Vemuri et al. 2011).
To the best of our knowledge, the importance of the frontal
lobes for the timing of predictive behavior has not been
demonstrated previously, neither in human nor in animal
studies.
The FEF and SEF might have a predominant role in eliciting
predictive reacceleration at the appropriate time for the four
following reasons. First, they are involved in timing represen-
tation during smooth pursuit eye movements (Schoppik et al.
2008). Second, neural learning emerges in FEF during an
oculomotor task that involves learning the timing of a change
in target direction (Li and Lisberger 2011). Third, the timing of
anticipatory pursuit is reflected in SEF neurons (de Hemptinne
et al. 2008). Finally, the observed deficit in predictive reaccel-
eration in mild FTLD can be associated with the early impair-
ment of both FEF and SEF in FTLD (Broe et al. 2003).
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the blanking of the target (0ms corresponds to target blanking onset). A: CTRL
subjects; B: FTLD patients; C: AD patients. White lines represent target
position. Color scales represent the probability that a saccade triggered during
the blanking period lands on a point. Target velocity was 20°/s.
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Fig. 6. Saccade-pursuit interactions. A: saccadic eye
displacement (SAD) during blanking vs. smooth
pursuit eye displacement (SED) during blanking, for
a typical FTLD patient (patient FTLD5). These dis-
placements were normalized by the target displace-
ment during blanking. Each dot represents one trial.
All trials are displayed, merging all velocities and
directions together. Continuous line represents the
linear fit and has a slope of 0.89. Dashed line
represents the optimal compensation, with slope
equal to 1. B: mean slope of the linear fits for
individual subjects. Each point represents the aver-
age for one subject across the three target velocities.
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Alternatively, the absence of predictive reacceleration might
also reflect a network disruption rather than damage to a
specific brain area. Changes in connectivity among brain areas
occur early in neurodegenerative disorders (Seeley et al. 2009;
Pievani et al. 2011). In FTLD, this connectivity change is
especially marked in the frontal lobes in FTLD patients (Zhou
et al. 2010). Predictive smooth pursuit relies on the connectiv-
ity between frontal areas more heavily during target blanking
than during visually guided tracking (Ding et al. 2009). There-
fore, this reliance on brain connectivity might explain why
FTLD results in a subtle deficit, different from those seen in
focal lesions (Morrow and Sharpe 1995; Heide et al. 1996;
Lekwuwa and Barnes 1996). However, it is surprising that the
interaction between the saccadic and pursuit systems was not
strongly affected given that it probably also relies on the
interaction between several areas (Krauzlis 2004, 2005; Orban
de Xivry and Lefèvre 2007).
The observed deficit might be linked to general time esti-
mation impairment in frontal lobe patients. Indeed, the frontal
lobes have been involved in several timing tasks (Lewis and
Miall 2003a; Buhusi and Meck 2005; Koch et al. 2009). For
instance, patients with frontal lesions are impaired in time
estimation (Harrington et al. 1998; Mimura et al. 2000; Koch
et al. 2002). However, this deficit is predominant for tasks in
the range of seconds but not at the millisecond time scale
(Mangels et al. 1998; Jones et al. 2004). Likewise, a timing
deficit has been reported in one FTLD patient with time
interval in the range of seconds (Wiener and Coslett 2008).
Moreover, AD patients also exhibit some deficits in time
estimation tasks (Caselli et al. 2009; Rueda and Schmitter-
Edgecombe 2009), even at the millisecond time scale. The
existence of different timing mechanisms for automatic and
cognitively controlled tasks (Lewis and Miall 2003b) might
explain why AD patients are impaired in cognitively controlled
estimation tasks but not in automatically controlled tasks (our
task).
What predictive smooth pursuit tells us about FTLD. FTLD
patients are difficult to differentiate from AD patients in the
early stages of the disease (Hampel et al. 2010; Hu et al. 2011;
Shaw et al. 2007). The diagnosis criteria of FTLD should be
supported by brain imaging (Piguet et al. 2011), which is the
case for every FTLD and AD patients included in the present
study. Indeed, classical executive tests used in clinic are not
always able to distinguish the groups at an early stage. In the
present study, even the executive tests used (Luria and TMT,
see MATERIALS AND METHODS) do not show differences between
the groups. Indeed, the aphasic subgroup of FTLD (6 patients)
is not supposed to be impaired for this kind of test and not all
behavioral FTD patients show deficits on formal executive
tests at an early stage. In some cases, the executive impairment
is purely behavioral, especially when the lesions are localized
in the inferior and medial part of the frontal lobes (Gregory et
al. 1999). Conversely, some mild AD patients may show
deficits on tests such as Luria and TMT for different reasons,
including incipient visuo-spatial deficits and forgetting the
wording. In contrast, our task was very sensitive to subtle
deficits present in early stage FTLD patients.
Based on predictive smooth pursuit measurements, we dif-
ferentiated FTLD patients from AD patients and controls. All
of the 15 controls and 10 out of 11 of the mild AD patients
exhibited a predictive reacceleration before target reappearance
while only 2 out of the 13 FTLD patients were able to do so.
This dramatic impairment of mild FTLD patients on a very
particular aspect of a smooth pursuit task compared with
healthy controls and mild AD patients highlights the potential
of this oculomotor task to isolate a cheap and efficient bio-
marker for FTLD.
Finally, it is important to highlight that the deficit of predic-
tive acceleration is present in a very early phase of the FTLD
when the usual measures of smooth pursuit are still normal.
This contrasts with earlier studies (Boxer et al. 2006; Garbutt
et al. 2008) with later stage FTLD patients (disease duration of
60 vs. 30 mo in this study) who already had impaired visually
guided smooth pursuit and with patients with focal lesions in
the frontal lobes (Morrow and Sharpe 1995; Heide et al. 1996;
Lekwuwa and Barnes 1996). Longitudinal follow-up will need
to evaluate whether the gain of the visually guided smooth
pursuit or any other characteristics of the oculomotor perfor-
mance could be used to assess the stage of FTLD.
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